Despite lower maximum peak values, increases in insulin and C-peptide levels lasted longer in T2DM patients and obese males with or without cardiovascular disease compared with healthy subjects (Blaak et al. 2006; Umpaichitra et al. 2004; Wu and Yu 2004; Wuesten et al. 2005). Here, INS is linked to type 2 diabetes mellitus.